Henry Schein (NASDAQ:HSIC) Price Target Lowered to $80.00 at UBS Group

Henry Schein (NASDAQ:HSIC) had its price objective cut by research analysts at UBS Group from $83.00 to $80.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective suggests a potential upside of 9.64% from the company’s current price.

Several other research firms have also commented on HSIC. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Finally, Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Eight equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $80.82.

Henry Schein Price Performance

Henry Schein stock traded down $2.86 during midday trading on Wednesday, reaching $72.96. 2,051,207 shares of the stock were exchanged, compared to its average volume of 1,631,889. The company’s fifty day moving average is $74.25 and its 200-day moving average is $72.43. The firm has a market cap of $9.10 billion, a PE ratio of 29.72, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

Several institutional investors have recently made changes to their positions in HSIC. Clarkston Capital Partners LLC increased its holdings in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares in the last quarter. Nuance Investments LLC raised its holdings in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares during the last quarter. Olstein Capital Management L.P. raised its holdings in shares of Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Henry Schein in the 3rd quarter valued at about $515,000. Finally, Equitable Trust Co. bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $417,000. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.